---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-075720"
form_type: "8-K"
ticker: "GPCR"
cik: "0001888886"
company_name: "Structure Therapeutics Inc."
filed_at: "2026-06-18T20:05:25+00:00"
generated_at: "2026-06-18T20:12:05.554866+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Structure Therapeutics shareholders elect directors, ratify auditor, approve say-on-pay at 2026 AGM

## Summary
- Elected Ted W. Love, Raymond Stevens, Daniel G. Welch as Class III directors with >161M votes for each.
- Ratified Ernst & Young as independent auditor for FY2026: 164.8M for, 20.8K against.
- Advisory vote on executive compensation approved: 158.5M for, 6.2M against, 212.7K abstentions.
- 213.2M ordinary shares outstanding as of record date April 20, 2026.

## SEC filing metadata
- accession: 0001104659-26-075720
- form_type: 8-K
- ticker: GPCR
- cik: 0001888886
- company_name: Structure Therapeutics Inc.
- filed_at: 2026-06-18T20:05:25+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1888886/000110465926075720/0001104659-26-075720-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1888886/000110465926075720/tm2618249d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-075720
- JSON: https://secwatch.observer/filing/0001104659-26-075720.json
- Plain text: https://secwatch.observer/filing/0001104659-26-075720.txt

## Key facts
- Shareholder Votes
  Structure Therapeutics Inc. shareholders approved Election of Directors at the 2026-06-17 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-17
  source text: Proposal 1: Election of Directors Ted W. Love M.D., Raymond Stevens, Ph.D. and Daniel G. Welch were elected as a Class III directors, to hold office until the 2029 Annual General Meeting of Shareholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1888886/000110465926075720/0001104659-26-075720-index.htm
- Shareholder Votes
  Structure Therapeutics Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-17 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-17
  source text: Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The Company’s shareholders ratified the appointment by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1888886/000110465926075720/0001104659-26-075720-index.htm
- Shareholder Votes
  Structure Therapeutics Inc. shareholders approved Advisory vote on the compensation of the Company’s named executive officers at the 2026-06-17 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-17
  source text: Proposal 3: Advisory vote on the compensation of the Company’s named executive officers On an advisory basis, the shareholders approved the compensation of the Company’s named executive officers, as disclosed in the Company’s proxy statement for the Annual General Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1888886/000110465926075720/0001104659-26-075720-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.